{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:10:48Z","timestamp":1779261048348,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s43032-020-00244-0","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T16:03:47Z","timestamp":1593705827000},"page":"2247-2256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-1592","authenticated-orcid":false,"given":"Charlotte","family":"Sonigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Le Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marouane","family":"Boubaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haykanush","family":"Ohanyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Press\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hady","family":"El Hachem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Cedrin-Durnerin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Sifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Sermondade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Grynberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"244_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1472-6483(10)61101-7","volume":"8","author":"R-C Chian","year":"2004","unstructured":"Chian R-C. In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod BioMed Online. 2004;8:547\u201352.","journal-title":"Reprod BioMed Online"},{"key":"244_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0015-0282(16)56891-5","volume":"62","author":"A Trounson","year":"1994","unstructured":"Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994;62:353\u201362.","journal-title":"Fertil Steril"},{"key":"244_CR3","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/humrep\/deh765","volume":"20","author":"P Humaidan","year":"2005","unstructured":"Humaidan P, Bredkjaer HE, Bungum L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20:1213\u201320.","journal-title":"Hum Reprod"},{"key":"244_CR4","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.fertnstert.2013.01.090","volume":"99","author":"M Grynberg","year":"2013","unstructured":"Grynberg M, El Hachem H, de Bantel A, et al. In vitro maturation of oocytes: uncommon indications. Fertil Steril. 2013;99:1182\u20138.","journal-title":"Fertil Steril"},{"key":"244_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.fertnstert.2017.08.020","volume":"108","author":"Z-Y Yang","year":"2017","unstructured":"Yang Z-Y, Chian R-C. Development of in vitro maturation techniques for clinical applications. Fertil Steril. 2017;108:577\u201384.","journal-title":"Fertil Steril"},{"key":"244_CR6","doi-asserted-by":"publisher","unstructured":"Creux H, Monnier P, Son W-Y, et al. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment. Fertil Steril. https:\/\/doi.org\/10.1016\/j.fertnstert.2016.09.041.","DOI":"10.1016\/j.fertnstert.2016.09.041"},{"key":"244_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/humrep\/dev325","volume":"31","author":"M Grynberg","year":"2016","unstructured":"Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients. Hum Reprod. 2016;31:623\u20139.","journal-title":"Hum Reprod"},{"key":"244_CR8","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1056\/NEJM199911183412118","volume":"341","author":"RC Chian","year":"1999","unstructured":"Chian RC, G\u00fclekli B, Buckett WM, et al. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med. 1999;341:1624\u20136.","journal-title":"N Engl J Med"},{"key":"244_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1472-6483(10)60263-5","volume":"18","author":"R Fadini","year":"2009","unstructured":"Fadini R, Dal Canto MB, Renzini MM, Brambillasca F, Comi R, Fumagalli D, et al. Predictive factors in in-vitro maturation in unstimulated women with normal ovaries. Reprod BioMed Online. 2009;18:251\u201361.","journal-title":"Reprod BioMed Online"},{"key":"244_CR10","doi-asserted-by":"publisher","first-page":"e0208576","DOI":"10.1371\/journal.pone.0208576","volume":"13","author":"H El Hachem","year":"2018","unstructured":"El Hachem H, Sonigo C, Benard J, et al. Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation. PLoS One. 2018;13:e0208576.","journal-title":"PLoS One"},{"key":"244_CR11","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1093\/humrep\/13.11.3132","volume":"13","author":"P Wynn","year":"1998","unstructured":"Wynn P, Picton HM, Krapez JA, Rutherford AJ, Balen AH, Gosden RG. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation. Hum Reprod. 1998;13:3132\u20138.","journal-title":"Hum Reprod"},{"key":"244_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/humrep\/15.1.165","volume":"15","author":"RC Chian","year":"2000","unstructured":"Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod. 2000;15:165\u201370.","journal-title":"Hum Reprod"},{"key":"244_CR13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/humupd\/dmq014","volume":"16","author":"W-Y Son","year":"2010","unstructured":"Son W-Y, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update. 2010;16:675\u201389.","journal-title":"Hum Reprod Update"},{"key":"244_CR14","first-page":"3984","volume":"83","author":"DS Willis","year":"1998","unstructured":"Willis DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab. 1998;83:3984\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"244_CR15","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1210\/jc.2012-1427","volume":"97","author":"JV Jeppesen","year":"2012","unstructured":"Jeppesen JV, Kristensen SG, Nielsen ME, Humaidan P, Dal Canto M, Fadini R, et al. LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab. 2012;97:E1524\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"244_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/humrep\/dew102","volume":"31","author":"C Sonigo","year":"2016","unstructured":"Sonigo C, Simon C, Boubaya M, Benoit A, Sifer C, Sermondade N, et al. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? Hum Reprod. 2016;31:1493\u2013500.","journal-title":"Hum Reprod"},{"key":"244_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/humrep\/17.1.134","volume":"17","author":"W-Y Son","year":"2002","unstructured":"Son W-Y, Yoon S-H, Lee S-W, Ko Y, Yoon HG, Lim JH. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from unstimulated patients with PCOS after in-vivo HCG priming. Hum Reprod. 2002;17:134\u20136.","journal-title":"Hum Reprod"},{"key":"244_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.fertnstert.2013.01.141","volume":"99","author":"R-C Chian","year":"2013","unstructured":"Chian R-C, Uzelac PS, Nargund G. In vitro maturation of human immature oocytes for fertility preservation. Fertil Steril. 2013;99:1173\u201381.","journal-title":"Fertil Steril"},{"key":"244_CR19","doi-asserted-by":"publisher","unstructured":"Creux H, Monnier P, Son W-Y, et al. Thirteen years\u2019 experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments. J Assist Reprod Genet. https:\/\/doi.org\/10.1007\/s10815-018-1138-0.","DOI":"10.1007\/s10815-018-1138-0"},{"key":"244_CR20","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10815-018-1153-1","volume":"35","author":"A Kedem","year":"2018","unstructured":"Kedem A, Yerushalmi GM, Brengauz M, Raanani H, Orvieto R, Hourvitz A, et al. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation. J Assist Reprod Genet. 2018;35:851\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"244_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.rbmo.2010.05.003","volume":"21","author":"E Shalom-Paz","year":"2010","unstructured":"Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod BioMed Online. 2010;21:566\u201371.","journal-title":"Reprod BioMed Online"},{"key":"244_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fertnstert.2010.06.064","volume":"95","author":"E Maman","year":"2011","unstructured":"Maman E, Meirow D, Brengauz M, Raanani H, Dor J, Hourvitz A. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril. 2011;95:64\u20137.","journal-title":"Fertil Steril"},{"key":"244_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.fertnstert.2015.11.027","volume":"105","author":"A Cobo","year":"2016","unstructured":"Cobo A, Garc\u00eda-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755\u2013764.e8.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"244_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1472-6483(12)60007-8","volume":"4","author":"SL Tan","year":"2002","unstructured":"Tan SL, Child TJ. In-vitro maturation of oocytes from unstimulated polycystic ovaries. Reprod BioMed Online. 2002;4(Suppl 1):18\u201323.","journal-title":"Reprod BioMed Online"},{"key":"244_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bpobgyn.2018.06.004","volume":"53","author":"ML Walls","year":"2018","unstructured":"Walls ML, Hart RJ. In vitro maturation. Best Pract Res Clin Obstet Gynaecol. 2018;53:60\u201372.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"244_CR26","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","volume":"32","author":"L Engmann","year":"2016","unstructured":"Engmann L, Benadiva C, Humaidan P. GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reprod BioMed Online. 2016;32:274\u201385.","journal-title":"Reprod BioMed Online"},{"key":"244_CR27","first-page":"CD008720","volume":"11","author":"J Reavey","year":"2016","unstructured":"Reavey J, Vincent K, Child T, et al. Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. Cochrane Database Syst Rev. 2016;11:CD008720.","journal-title":"Cochrane Database Syst Rev"},{"key":"244_CR28","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1210\/jc.2015-3878","volume":"101","author":"J Kim","year":"2016","unstructured":"Kim J, Turan V, Oktay K. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. J Clin Endocrinol Metab. 2016;101:1364\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1387\/ijdb.120135gv","volume":"56","author":"G Coticchio","year":"2012","unstructured":"Coticchio G, Dal-Canto M, Guglielmo M-C, Mignini-Renzini M, Fadini R. Human oocyte maturation in vitro. Int J Dev Biol. 2012;56:909\u201318.","journal-title":"Int J Dev Biol"},{"key":"244_CR30","doi-asserted-by":"publisher","first-page":"e46682","DOI":"10.1371\/journal.pone.0046682","volume":"7","author":"L Casarini","year":"2012","unstructured":"Casarini L, Lispi M, Longobardi S, Milosa F, la Marca A, Tagliasacchi D, et al. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling. PLoS One. 2012;7:e46682.","journal-title":"PLoS One"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00244-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-020-00244-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00244-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:31Z","timestamp":1625184031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-020-00244-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s43032-020-00244-0","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Local Ethical Committee (Comit\u00e9 de Protection des Personnes Ile de France X; no. ID RCB: 2014-A00819-38) before the first enrollment. The study was retrospectively registered to clinical trial (ID NCT03954197) in May 2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients gave their written consent to participate to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All patients agreed for the publication of the data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}